BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control

Immunity

Volumn 13, Issue 2, 2000, Pages 199-212

  Shaffer, A L ^a   Yu, Xin ^a   He, Yunsheng ^a   Boldrick, Jennifer ^a   Chan, Erick P ^a   Staudt, Louis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MYC PROTEIN; PROTEIN BCL 6; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRESSOR GENE; TRANSCRIPTION REGULATION;

EID: 0033680860     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)00020-0     Document Type: Article

References (52)

1. The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes
2. Identification of molecularly and clinically distinct types of diffuse large B-cell lymphoma by gene expression prof ling
3. BCL-6 expression during B-cell activation
4. BCL6 encodes a sequence-specific DNA-binding protein
5. Regulation and function of transcription factor GATA-1 during red blood cell differentiation
6. High levels of CD44 expression distinguish virgin from antigen-primed B cells
7. Immature stage B cells enter but do not progress beyond the early G1 phase of the cell cycle in response to antigen receptor signaling
8. Bcl-6 protein is expressed in germinal-center B cells
9. Interaction of proteins with transcriptionally active estrogen receptors
10. Requirement of MIP-1 α for an inflammatory response to viral infection
11. Molecular pathogenesis of B cell malignancy: The role of BCL-6
12. Novel BTB/POZ domain zinc-finger protein LRF, is a potential target of the LAZ-3/BCL-6 oncogene
13. Control of inflammation, cytokine expression, and germinal center formation by BCL-6
14. Cluster analysis and display of genome-wide expression patterns
15. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
16. Mig and IP-10: CXC chemokines that target lymphocytes
17. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
18. The murine gene p27Kip1 is haplo-insufficient for tumour suppression
19. Analysis of the hormone-dependent regulation of a JunD-estrogen receptor chimera
20. Disruption of the Bcl6 gene results in an impaired germinal center formation
21. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4
22. Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: Specific regulation of iepsilon transcription and immunoglobulin E switching
23. Characterization of the murine cyclin D2 gene: Exon/intron organization and promoter activity
24. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
25. Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 family
26. Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 α) and MIP-1 β chemokine production in human B cells
27. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation
28. Human peripheral B cell subsets
29. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-α-responsive elements
30. Macrophage inflammatory protein-1 α influences eosinophil recruitment in antigen-specific airway inflammation
31. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development
32. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes
33. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
34. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts
35. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
36. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor
37. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination
38. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells
39. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes
40. Transcriptional repression by the proto-oncogene BCL-6
41. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth
42. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes
43. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells
44. Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6
45. p27, A novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
46. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells
47. c-Myc induces the expression and activity of ornithine decarboxylase
48. Co-ligation of surface IgM and CD40 on naive B lymphocytes generates a blast population with an ambiguous extrafollicular/germinal centre cell phenotype
49. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1α, and MIP-1β, members of the chemokine superfamily of proinflammatory cytokines
50. Cloning and functional analysis of rat cyclin D2 promoter: Multiple prolactin-responsive elements
51. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation